Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)

PHASE3RecruitingINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

Lithium Carbonate 400 MG

Lithium carbonate vs placebo (2:1)

Trial Locations (13)

3000

RECRUITING

University Hospital Leuven, Leuven

SA 5042

NOT_YET_RECRUITING

Flinders Medical Centre, Adelaide

QLD 4029

NOT_YET_RECRUITING

Royal Brisbane and Women's Hospital, Brisbane

VIC 3195

NOT_YET_RECRUITING

Calvary Health Care Bethlehem, Parkdale

WA 6009

NOT_YET_RECRUITING

Perron Institute, Perth

NSW 2050

RECRUITING

The University of Sydney (Royal prince Alfred hospital), Sydney

NSW 2139

NOT_YET_RECRUITING

Concord hospital Sydney, Sydney

3584 CX

RECRUITING

University Medical Center Utrecht, Utrecht

08907

RECRUITING

Bellvitge University Hospital, Barcelona

171 64

RECRUITING

Karolinska University Hospital, Stockholm

SE5 9RS

RECRUITING

King's College Hospital, London

WC1N 3BG

NOT_YET_RECRUITING

University College London Hospital NHS, London

ST4 6QG

NOT_YET_RECRUITING

University Hospitals of North Midlands NHS Trust, Stoke-on-Trent

All Listed Sponsors
collaborator

Fight MND

UNKNOWN

collaborator

Research Foundation Flanders

OTHER

collaborator

MNDA

UNKNOWN

collaborator

Thierry Latran Foundation

UNKNOWN

collaborator

Ulla-Carin Lindquist Foundation

UNKNOWN

collaborator

Luzon Foundation

UNKNOWN

collaborator

Alan Davidson Foundation

UNKNOWN

collaborator

My name'5 Doddie Foundation

UNKNOWN

collaborator

Stichting ALS Nederland

UNKNOWN

lead

Stichting TRICALS Foundation

OTHER

NCT06008249 - Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter | Biotech Hunter